Stable Cas9 Expression Regulates Cell Growth via mTORC2 Activation: Mechanistic Insights and Implications for Phosphorylation Studies

Study Background and Research Question

The CRISPR/Cas9 system has fundamentally transformed molecular biology, enabling targeted genome editing for functional genomics, disease modeling, and therapeutic development. While its utility is widely recognized, the biological consequences of prolonged Cas9 expression within mammalian cells remain incompletely characterized. The reference study by Yu et al. (Nucleic Acids Research, 2025) addresses a critical gap: does sustained Cas9 presence influence cellular physiology beyond its intended genomic targets? Specifically, the investigators sought to determine whether stable Cas9 expression modulates cell growth and to elucidate the underlying molecular mechanisms.

Key Innovation from the Reference Study

Yu et al. provide the first systematic analysis of how constitutive Cas9 expression affects the proliferation of a diverse panel of mammalian cell lines. Their work uncovers a previously unappreciated function of Cas9: it acts as a scaffold linking ribosomal proteins to components of the mTORC2 signaling complex, thereby promoting mTORC2 activation and cell growth. This mechanistic insight advances our understanding of CRISPR technology’s biological footprint and introduces a new dimension to the evaluation of gene editing systems for both research and clinical use.

Methods and Experimental Design Insights

The study employed a robust experimental framework to dissect Cas9’s cellular impact:

• Cell line profiling: 32 cell lines spanning nine cancer types and non-cancerous controls were engineered to stably express SpCas9. Growth rates were systematically quantified, revealing that only a subset displayed altered proliferation.
• Interactome mapping: Using immunoprecipitation and mass spectrometry in DU145 (prostate cancer) and MDA-MB-231 (breast cancer) cells—both exhibiting Cas9-enhanced growth—the authors defined the SpCas9 interactome. Ribosomal proteins, notably RPL26 and RPL23a, emerged as top interactors.
• Transcriptomic analysis: RNA sequencing of Cas9-expressing DU145 cells identified upregulation of PI3K signaling pathways, suggesting changes in growth-regulatory networks.
• Mechanistic validation: Biochemical assays confirmed that Cas9 physically interacts with both ribosomal proteins and Sin1, a core mTORC2 component, stabilizing their association and enhancing mTORC2 activation—even in the absence of exogenous growth factors.

Such a multi-layered approach allows for the dissection of both direct protein–protein interactions and downstream transcriptional effects, strengthening the causal link between Cas9 expression and altered cell behavior.

Core Findings and Why They Matter

Yu et al. (2025) report several key discoveries with significant implications for the CRISPR research community:

• Selective growth modulation: Stable Cas9 expression enhances cell proliferation in a context-dependent manner, affecting only certain cell types.
• Cas9 as a signaling scaffold: The study reveals that Cas9 forms a nexus between RPL26/RPL23a ribosomal proteins and Sin1, facilitating mTORC2 activation. This direct protein–protein bridging is independent of Cas9’s endonuclease activity or guide RNA presence.
• Growth factor independence: Cas9-stabilized mTORC2 activation occurs even in serum-free conditions, indicating a bypass of classical extracellular signaling inputs.
• Implications for experimental interpretation: These findings highlight the potential for Cas9 to introduce non-genomic, phosphorylation-driven changes to cell signaling, which may confound the interpretation of CRISPR-based functional screens or phenotyping assays.

Given the central role of mTORC2 in cell survival, metabolism, and cancer biology, the discovery of a Cas9-mediated regulatory axis necessitates careful control and validation in CRISPR experiments, particularly those examining proliferation or phosphorylation-dependent endpoints.

Comparison with Existing Internal Articles

Several internal resources provide practical strategies for maintaining protein phosphorylation integrity during cell signaling studies, which directly relate to the workflows examined by Yu et al. For instance, the article "Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Reliable..." emphasizes the importance of dual-tube phosphatase inhibitor systems for preserving labile phosphorylation states during immunoblotting and kinase activity assays. Similarly, "Phosphatase Inhibitor Cocktail 100X: Enabling Advanced Ph..." discusses workflow optimizations for robust protein phosphorylation preservation in advanced signaling studies, which is crucial for accurate detection of mTORC2 pathway activity.

These resources converge on the recommendation that rigorous inhibition of both serine/threonine and tyrosine phosphatases is essential for reliable measurement of phosphorylation-dependent signaling, as exemplified by protocols used in the reference study. Notably, the preservation of phosphorylation status is particularly important when assessing kinases and downstream effectors in mechanistic studies like those performed by Yu et al., where mTORC2 activity is central.

Limitations and Transferability

While the reference study provides compelling mechanistic evidence, several limitations warrant consideration:

• Cell type specificity: Only a subset of cell lines responded to Cas9 expression with growth alterations, suggesting that context-dependent factors—such as ribosomal protein expression or pre-existing mTORC2 activity—modulate the effect.
• Focus on SpCas9: The findings are specific to Streptococcus pyogenes Cas9 and may not generalize to other Cas9 orthologs or gene editing nucleases.
• Translational uncertainty: While the identified Cas9-ribosome-mTORC2 axis is robust in vitro, its physiological relevance in vivo, especially in therapeutic settings, remains to be fully established.
• Phosphorylation dynamics: The study’s mechanistic conclusions rely on sensitive detection of phosphorylation events, underscoring the need for stringent sample handling protocols to avoid artifactual dephosphorylation.

Researchers should carefully consider these factors when designing CRISPR experiments or interpreting phenotypic outcomes in edited cells.

Protocol Parameters

• Stable Cas9 expression: Lentiviral transduction and antibiotic selection were used to ensure persistent SpCas9 expression in target cell lines over multiple passages (Yu et al., 2025).
• Immunoprecipitation sample preparation: Cells were lysed in ice-cold buffer containing comprehensive phosphatase inhibitor cocktails to preserve endogenous protein phosphorylation, enabling reliable detection of mTORC2 activation.
• Growth factor withdrawal: Serum-free media were used to test mTORC2 activation independent of extracellular signals, highlighting the direct role of Cas9 in pathway modulation.
• Phosphorylation analysis: Immunoblotting for phospho-Akt (Ser473) served as a readout of mTORC2 kinase activity.
• Recommended workflow: For optimal preservation of phosphorylation states during cell lysis, samples should be supplemented with a broad-spectrum phosphatase inhibitor cocktail immediately upon harvest, as also advocated by internal expertise (Protein Phosphorylation Integrity: Translational Strategy Blueprint).

Outlook: Implications for Future CRISPR Research

The discovery that stable Cas9 expression can act as a scaffold to promote mTORC2 activation and enhance cell growth has broad-reaching implications. In addition to raising new safety considerations for CRISPR-based therapies—where off-target effects have historically centered on genome integrity—these findings prompt a re-examination of Cas9’s non-genomic functions. Future work should focus on engineering Cas9 variants with reduced propensity for unintended protein–protein interactions and on developing standardized protocols for phosphorylation preservation in CRISPR workflows. The integration of rigorous biochemical controls, including validated phosphatase inhibitor strategies, will be essential for reproducibility and data fidelity in signaling studies.

Research Support Resources

To ensure reliable protein phosphorylation preservation during sample preparation—critical for studies interrogating signaling pathways such as mTORC2—researchers may utilize reagents like the Phosphatase Inhibitor Cocktail (2 Tubes, 100X) (SKU K1015). This dual-component system supports high-fidelity detection of phosphorylation events by inhibiting both serine/threonine and tyrosine protein phosphatases, as outlined in internal guidance and product information. Incorporating such tools into immunoblotting, immunoprecipitation, and kinase activity assay workflows can help maintain the integrity of signaling data in studies analogous to those reported by Yu et al. (2025). APExBIO’s solution is intended exclusively for scientific research use and is not for diagnostic purposes.